Anuj Suri, MD

Assistant Professor of Clinical Obstetrics and Gynecology, Institute for Academic Medicine
Houston Methodist


Publications

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Suri, A, Sheng, X, Schuler, KM, Zhong, Y, Han, X, Jones, HM, Gehrig, PA, Zhou, C & Bae-Jump, VL 2016, Oncotarget, vol 7, no. 26, pp. 39582-39594.

Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors
Suri, A, Carter, EB, Horowitz, N, Denslow, S & Gehrig, PA 2013, Gynecologic Oncology, vol 131, no. 2, pp. 321-324. DOI: 10.1016/j.ygyno.2013.08.013

Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumors
Stine, JE, Suri, A, Gehrig, PA, Chiu, M, Erickson, BK, Huh, WK, Soper, JT, Le, LV, Conner, MG & Kim, KH 2013, Gynecologic Oncology, vol 131, no. 1, pp. 59-62. DOI: 10.1016/j.ygyno.2013.06.030

Minimally invasive surgery in endometrial cancer: Recent updates
Doll, KM, Suri, A & Gehrig, PA 2013, Expert Review of Obstetrics and Gynecology, vol 8, no. 3, pp. 271-283. DOI: 10.1586/eog.13.14

Discussion: 'Ovarian epithelial carcinoma with pelvic endometriosis,' by Wang et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Doll, K, Stine, J & Kim, K 2013, American Journal of Obstetrics and Gynecology, vol 208, no. 5. DOI: 10.1016/j.ajog.2013.03.014

Ovarian epithelial carcinoma with pelvic endometriosis: Wang et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Doll, K, Stine, J & Kim, K 2013, American Journal of Obstetrics and Gynecology, vol 208, no. 5, pp. 415-416. DOI: 10.1016/j.ajog.2013.03.004

Surgical staging in early ovarian carcinoma: Garcia-Soto et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Kilgore, J, Ko, E, Gehrig, P & Brewster, W 2012, American Journal of Obstetrics and Gynecology, vol 206, no. 3, pp. 263-264. DOI: 10.1016/j.ajog.2012.01.019

Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Kilgore, J, Ko, E, Gehrig, P & Brewster, W 2012, American Journal of Obstetrics and Gynecology, vol 206, no. 3. DOI: 10.1016/j.ajog.2012.01.020

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations missed opportunities
Meyer, LA, Anderson, ME, Lacour, RA, Suri, A, Daniels, MS, Urbauer, DL, Nogueras-Gonzalez, GM, Schmeler, KM, Gershenson, DM & Lu, KH 2010, Obstetrical and Gynecological Survey, vol 65, no. 7, pp. 436-437. DOI: 10.1097/OGX.0b013e3181e62f2d

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: Missed opportunities
Meyer, LA, Anderson, ME, Lacour, RA, Suri, A, Daniels, MS, Urbauer, DL, Nogueras-Gonzalez, GM, Schmeler, KM, Gershenson, DM & Lu, KH 2010, Obstetrics and Gynecology, vol 115, no. 5, pp. 945-952. DOI: 10.1097/AOG.0b013e3181da08d7

Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer
Suri, A, Frumovitz, M, Milam, MR, dos Reis, R & Ramirez, PT 2009, Gynecologic Oncology, vol 112, no. 1, pp. 110-113. DOI: 10.1016/j.ygyno.2008.09.011